Esther Rajavelu
Stock Analyst at UBS
(0.63)
# 3,932
Out of 4,944 analysts
26
Total ratings
42.86%
Success rate
-24.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Neutral | $45 → $46 | $42.88 | +7.28% | 4 | Aug 12, 2025 | |
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.45 | +342.38% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $14.46 | +121.30% | 2 | Apr 9, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $141 → $215 | $439.32 | -51.06% | 5 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $28.94 | +152.25% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $14.16 | +669.77% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $16.80 | +108.33% | 1 | May 18, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $115.69 | +97.08% | 1 | Mar 1, 2021 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $18.64 | - | 1 | Dec 13, 2019 | |
| INVA Innoviva | Initiates: Hold | $13 | $20.71 | -37.23% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.15 | +771.92% | 1 | Jul 21, 2017 |
Ionis Pharmaceuticals
Aug 12, 2025
Maintains: Neutral
Price Target: $45 → $46
Current: $42.88
Upside: +7.28%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.45
Upside: +342.38%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $14.46
Upside: +121.30%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141 → $215
Current: $439.32
Upside: -51.06%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $28.94
Upside: +152.25%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $14.16
Upside: +669.77%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $16.80
Upside: +108.33%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $115.69
Upside: +97.08%
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $18.64
Upside: -
Innoviva
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $20.71
Upside: -37.23%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.15
Upside: +771.92%